Brokerages Set Alignment Healthcare, Inc. (NASDAQ:ALHC) PT at $18.83

Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) have earned a consensus recommendation of “Moderate Buy” from the twelve research firms that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation, six have issued a buy recommendation and two have assigned a strong buy recommendation to the company. The average twelve-month price target among analysts that have covered the stock in the last year is $18.8333.

A number of brokerages have recently weighed in on ALHC. Barclays raised shares of Alignment Healthcare from an “underweight” rating to an “equal weight” rating and boosted their price objective for the company from $9.00 to $13.00 in a report on Thursday, July 31st. KeyCorp upgraded shares of Alignment Healthcare from a “sector weight” rating to an “overweight” rating and set a $21.00 price objective on the stock in a research note on Monday, August 25th. Zacks Research upgraded Alignment Healthcare from a “hold” rating to a “strong-buy” rating in a research report on Monday, September 29th. Weiss Ratings reissued a “sell (d-)” rating on shares of Alignment Healthcare in a research note on Saturday, September 27th. Finally, Wall Street Zen lowered Alignment Healthcare from a “buy” rating to a “hold” rating in a report on Sunday, August 10th.

Alignment Healthcare Price Performance

NASDAQ ALHC opened at $16.62 on Wednesday. The company has a market cap of $3.29 billion, a PE ratio of -59.36 and a beta of 1.18. The firm’s 50 day moving average price is $15.59 and its 200-day moving average price is $15.65. The company has a debt-to-equity ratio of 2.29, a quick ratio of 1.66 and a current ratio of 1.66. Alignment Healthcare has a 52-week low of $10.11 and a 52-week high of $21.06.

Alignment Healthcare (NASDAQ:ALHC) last announced its quarterly earnings results on Wednesday, July 30th. The company reported $0.07 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.14. Alignment Healthcare had a negative return on equity of 43.68% and a negative net margin of 1.53%.The business had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $960.25 million. During the same period last year, the business posted ($0.13) EPS. The business’s revenue was up 49.0% compared to the same quarter last year. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Sell-side analysts forecast that Alignment Healthcare will post -0.69 EPS for the current fiscal year.

Insider Activity at Alignment Healthcare

In related news, President Dawn Christine Maroney sold 215,662 shares of the firm’s stock in a transaction dated Wednesday, September 10th. The shares were sold at an average price of $16.41, for a total transaction of $3,539,013.42. Following the completion of the sale, the president directly owned 1,797,237 shares in the company, valued at approximately $29,492,659.17. This trade represents a 10.71% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Atlantic (Aln Hlth) L. General sold 6,246,096 shares of the stock in a transaction on Wednesday, September 17th. The stock was sold at an average price of $16.01, for a total value of $99,999,996.96. Following the transaction, the director owned 24,596,079 shares of the company’s stock, valued at approximately $393,783,224.79. This represents a 20.25% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 7,388,173 shares of company stock worth $118,068,256 over the last 90 days. Corporate insiders own 6.60% of the company’s stock.

Institutional Trading of Alignment Healthcare

Several institutional investors have recently added to or reduced their stakes in ALHC. Teacher Retirement System of Texas boosted its position in shares of Alignment Healthcare by 109.1% during the first quarter. Teacher Retirement System of Texas now owns 47,447 shares of the company’s stock worth $883,000 after buying an additional 24,755 shares during the period. New York State Common Retirement Fund increased its stake in shares of Alignment Healthcare by 100.9% during the first quarter. New York State Common Retirement Fund now owns 165,642 shares of the company’s stock worth $3,084,000 after buying an additional 83,187 shares during the period. Victory Capital Management Inc. raised its holdings in Alignment Healthcare by 905.7% in the first quarter. Victory Capital Management Inc. now owns 114,397 shares of the company’s stock valued at $2,130,000 after acquiring an additional 103,022 shares in the last quarter. GAMMA Investing LLC grew its holdings in Alignment Healthcare by 3,216.9% during the 1st quarter. GAMMA Investing LLC now owns 23,815 shares of the company’s stock worth $443,000 after acquiring an additional 23,097 shares in the last quarter. Finally, Raymond James Financial Inc. increased its position in shares of Alignment Healthcare by 31.1% in the 1st quarter. Raymond James Financial Inc. now owns 206,174 shares of the company’s stock valued at $3,839,000 after purchasing an additional 48,901 shares during the last quarter. Institutional investors and hedge funds own 86.19% of the company’s stock.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.